Stayble Therapeutics AB
559024-8372ActiveDeveloping an injection treatment for pain caused by disc herniation.
Översikt
- 5–9
- Anställda
- 300–399t SEK
- Omsättning
- 2015
- Grundat
Nyckelbeslutsfattare
Andreas Gerward
CEO
Anders Lehmann
Chief Scientific Officer
Erik Kullgren
CFO
Gunnar Fernström
Board member
+4 fler kontakter i Funnelfeedr
Beskrivning
Stayble Therapeutics is a clinical pharmaceutical company focused on developing innovative treatments for debilitating leg pain caused by Lumbar Disc Herniation (LDH). Their core product candidate, STA363, is a patented, disease-modifying treatment administered via a single injection. This therapy a...
Taggar
Nyckelord
Företagsinformation
- Bransch
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559024837201
Beslutsfattare
8 kontakter i FunnelfeedrAndreas Gerward
CEO
Anders Lehmann
Chief Scientific Officer
Erik Kullgren
CFO
Gunnar Fernström
Board member
Ulf Björklund
Chairman of the Board
Jane Buus Laursen
Board member
Gudrun Anstrén
Board member
Erik Kinnman
Board member
Liknande företag
20 liknande företag i FunnelfeedrSynartro AB
1–4 anställdaDeveloping sustained local injection treatments for osteoarthritis pain relief.
Paayia Thaimassage
Professional traditional Thai massage services offered in Örebro.
Pharmnovo Aktiebolag
1–4 anställdaDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Intercedo AB
0 anställdaDeveloping medical products focused on improving quality of life.
PILA PHARMA AB
1–4 anställdaClinical stage biotech developing an oral obesity and diabetes treatment.
Utforska mer
Frågor om Stayble Therapeutics AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo